(Press-News.org) One in three severely affected adults with ME in England have no access to local specialist services, new research has shown.
Published in the British Medical Journal Open, the research by the University of Southampton reveals NICE guidelines, which say severely affected patients with ME, otherwise known as chronic fatigue syndrome (CFS), should have access to specialist care, are not being met by many NHS Trusts across England.
Over a third of specialist adult ME/CFS services in the NHS provide no service to severely affected patients, and a further 12 per cent of trusts provide only minimal or occasional help to housebound patients, primarily due to lack of funding.
It is estimated that ME/CFS can affect up to 250,000 people – children as well as adults – in the UK. It leaves people with debilitating physical and mental fatigue and pain. Severely affected individuals can become housebound, wheelchair or bedbound and dependent on carers for all basic activities of daily life. Around 25% are thought to have severe ME/CFS.
Researchers warn that many severely affected patients are going unnoticed and untreated.
Clare McDermott, NIHR School for Primary Care Research funded Doctoral Research Fellow at the University of Southampton, led the study and had ME/CFS when she was younger. She comments: "People with ME should be able to seek the advice of a specialist service close to their homes. We were surprised by the lack of services and access to services that our survey revealed. Even if the local Trust provides a service, some housebound patients will never get to use it. Many, very ill patients are going without."
The research surveyed all 49 NHS specialist ME/CFS adult services in England in 2013. Of these services, one in three (33 per cent) provided no service for severely affected, housebound patients while 55 per cent of services did treat patients with severe CFS/ME and the study found that their interventions followed the NICE Guidelines. The remaining services (12 per cent) offered occasional or minimal support where funding allowed. There was one NHS unit providing specialist inpatient CFS/ME care in England.
Jenny Patterson is 20 years old and has had ME/CFS for the last 10 years. During her worst days Jenny was bedbound, only able to get up to go to the toilet and had to be cared for full-time by her mother Frances. However in the past three years she has greatly improved due to the specialist service she has had access to. Jenny still requires full-time care but she is now able to go outside for short periods of time and have visitors. She credits her recovery to the specialist care she has recently received.
Jenny comments: "My quality of life has dramatically improved from how it was three years ago. Being housebound is an awful and isolating feeling. What I am able to cope with during the day is now carefully monitored and my routines are very important to prevent a relapse.
"I have been very fortunate to receive specialist care in the past three years. My ongoing recovery and how well I am improving is down to them. Unfortunately most people with severe ME don't have any access to specialist services, they can't get to a hospital or their Trust can't get services to them. Access to a specialist has undoubtedly changed my life; more people with this debilitating condition should have access to better care."
The Association of Young People with ME (AYME), of which Jenny is a member, is one organisation which has long-since spoken of the urgent need for specialist care.
The charity's chief executive, Mary-Jane Willows, says: "We have over 3,600 members who are all young people with ME. As the paper discusses, severe ME/CFS patients present particular clinical risks. What we see at AYME is the devastation caused by this condition, to the lives of young adults, children and their families. Patients are isolated at home, missing years of education and suffering extensive pain. Life for many is a darkened room they can rarely leave, with visits lasting a few short moments as that is all their bodies can tolerate."
The Southampton team are now conducting a pilot study to evaluate a community based intervention that will aim to reach the most severely affected people with ME/CFS. This intervention has been devised through a two-year patient and public development process which involved over 40 people with ME and carers, as well as many specialist health professionals. People with first-hand experience of getting better from ME have played a central role in helping to design the study, in order to explore strategies that can reach and meet the needs of the most vulnerable housebound people. The development work and study design were presented to the All Party Parliamentary Group on ME in March 2013 and results are expected in 2016.
INFORMATION:
Patients with severe ME have little or no access to specialist treatment services
2014-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Nature of solids and liquids explored through new pitch drop experiment
2014-07-02
VIDEO:
The movie clip shows the bitumen flow from the top camera view, and corresponds to approximately 24 days of real time.
Click here for more information.
Physicists at Queen Mary University of London have set up a new pitch drop experiment for students to explore the difference between solid and liquids.
Known as the 'world's longest experiment', the set up at the University of Queensland was famous for taking ten years for a drop of pitch – a thick, black, sticky ...
New study involving CU-Boulder tells the tale of a kangaroo's tail
2014-07-02
VIDEO:
This video is an analysis of video of kangaroos walking has helped scientists discover how important their tails are during locomotion.
Click here for more information.
Kangaroos may be nature's best hoppers. But when they are grazing on all fours, which is most of the time, their tail becomes a powerful fifth leg, says a new study.
Involving researchers at the University of Colorado Boulder, Simon Fraser University in Burnaby, Canada, and the University of New ...
The Lancet: Nearly 80 percent of US deaths in the first three decades of life are due to unintentional injury or violence
2014-07-02
A new report on unintentional injury and violence in the United States, published in The Lancet as part of a new Series, The health of Americans [1], has found that prevention strategies across society show a great deal of promise in preventing unintended deaths and injuries.
According to the report, by CDC researchers from Atlanta, USA, more Americans between the ages of one and 30 die from injury than from any other cause. Every year, nearly 180 000 people in the USA die from preventable causes such as automobile crashes, drowning, firearm-related injuries, falls, ...
The Lancet: Infectious diseases cause significant burden in the USA
2014-07-02
Infectious diseases remain major public health challenges in the United States, according to a new report published in The Lancet as part of a new Series, The health of Americans [1]. Endemic conditions such as chronic viral hepatitis, human immunodeficiency virus, and other sexually transmitted infections continue to affect millions of individuals, with racial and ethnic minorities disproportionately affected. Emerging and re-emerging vector borne and zoonotic disease infections are threatening new areas and populations, as most recently observed with Chikungunya. Despite ...
The Lancet: Chronic disease prevention one of 21st century's key challenges
2014-07-02
According to a report on chronic diseases by Centers for Disease Control and Prevention researchers, published in The Lancet as part of a new Series, The health of Americans [1], half of all adults in the USA suffer from at least one chronic condition, such as diabetes, heart disease, or obesity, and over a quarter of adults have two or more. The majority of these chronic conditions stem from a small number of risk factors that are largely preventable, including tobacco use, poor diet, and physical inactivity (both strongly associated with obesity), alcohol consumption, ...
Predicting the outcome of hepatitis C virus treatment
2014-07-02
Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully treat HCV. Unfortunately, antiviral therapy fails in some patients, resulting in a relapse of HCV. A study published in the Journal of Clinical Investigation identifies a marker that can identify patients likely to have an HCV relapse after antiviral therapy. Shyamasundaran Kottilil and colleagues at the NIH evaluated the immune response of HCV-infected ...
Bone marrow transplantation shows potential for treating adults with sickle cell disease
2014-07-01
Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA.
Myeloablative (use of high-dose chemotherapy or radiation) allogeneic hematopoietic stem cell transplantation (HSCT; receipt of hematopoietic stem cells "bone marrow" from another individual) is curative for children with severe sickle cell disease, but associated toxicity has made the procedure prohibitive for adults. The development of nonmyeloablative conditioning ...
Drug everolimus does not improve overall survival in patients with advanced liver cancer
2014-07-01
Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study in the July 2 issue of JAMA.
Patients with advanced hepatocellular carcinoma (HCC; a type of liver cancer) have a median overall survival of less than l year, largely because of the absence of effective therapies. The drug sorafenib is the only systemic therapy shown to significantly improve overall survival in advanced HCC; however its benefits are mostly transient and modest, and disease eventually ...
Study examines neurological outcomes for TBI treatments
2014-07-01
In patients with a traumatic brain injury (TBI), neither the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin concentration through blood transfusion resulted in improved neurological outcome at 6 months, according to a study in the July 2 issue of JAMA. Transfusing at higher hemoglobin concentrations was associated with a higher risk of adverse events.
Patients with severe traumatic brain injury commonly develop anemia. For patients with neurological injury, anemia is a potential cause of secondary injury, which may worsen neurological ...
Whole-exome sequencing helpful to id gene mutations linked to nervous system diseases
2014-07-01
Use of exome sequencing improved the ability to identify the underlying gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes (enzymes that are involved in basic energy production), according to a study in the July 2 issue of JAMA.
Defects of the mitochondrial respiratory chain have emerged as the most common cause of childhood and adult neurometabolic disease, with an estimated prevalence of l in 5,000 live births. Clinically these disorders can present at any time of life, are often seen in association ...